Proliferative activity of well differentiated neuroendocrine tumours of the gut

Histology and Histopathology

Volumn 18, Issue 2, 2003, Pages 353-358

  Zimmermann, M E ^a   Bosman, Fred T ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Digestive tract; Ki 67; Proliferation; Well differentiated neuroendocrine tumours

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN;

ADULT; AGE; AGED; ANTIBODY LABELING; APPENDIX TUMOR; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLON TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM TUMOR; FEMALE; GASTROINTESTINAL TUMOR; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MORPHOLOGY; NEUROENDOCRINE SYSTEM; NEUROENDOCRINE TUMOR; PROGNOSIS; RECTUM TUMOR; SEX DIFFERENCE; SMALL INTESTINE TUMOR; STATISTICAL ANALYSIS; STOMACH TUMOR; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CELL DIVISION; CELL NUCLEUS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS;

EID: 0037378008     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Al-Khafaji B., Noffsinger A.E., Miller M.A., DeVoe G., Stemmermann G.N. and Fenoglio-Preiser C. (1998). Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumours. Hum. Pathol. 29, 992-999.
2. Böhm J., Koch S., Gais P., Jutting U., Prauer H.W. and Hofler H. (1996). Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J. Pathol. 178, 402-409.
3. Bornstein-Quevedo L. and Gamboa-Dominguez A. (2000). Carcinoid tumors of the duodenum and ampulla of vater: A clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum. Pathol. 32, 1252-1256.
4. Burke A.P., Thomas R.M., Elsayed A.M. and Sobin L.H. (1997). Carcinoids of the jejunum and ileum: An immunohistochemical and clinicopathologic study of 167 cases. Cancer 79, 1086-1093.
5. Canavese G., Azzoni C., Pizzi S., Corleto V.D., Pasquali C., Davoli C., Crafa P., Delle Fave G. and Bordi C. (2001). p17: A potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum. Pathol. 32, 1094-1101.
6. Capella C., Heitz P.U., Hofler H., Solcia E. and Kloppel G. (1995). Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Archiv. 425, 547-560.
7. Costes V., Marty-Ane C., Picot M.C., Serre I., Pujol J.L., Maury H. and Baldet P. (1995). Typical and atypical bronchopulmonary carcinoid tumours: A clinicopathologic and KI-67-labeling study. Hum. Pathol. 26, 740-745.
8. Duchrow M., Gerdes J. and Schluter C. (1994). The proliferation-associated Ki-67 protein: Definition in molecular terms. Cell Proliferation 27, 235-242.
9. Fenoglio-Preiser C.M., Pascal R.R. and Perzin K.H. (1989). Carcinoid tumours. In: Tumours of the Intestines. Armed Forces Institutes of Pathology. pp 265-335.
10. Gentil Perret A., Mosnier J.F., Buono J.P., Berthelot P., Cipponi J., Ballique J.G., Cuillerck J., Dechelotte P. and Boucheron S. (1998). The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumours. Am. J. Clin. Pathol. 109, 286-293.
11. Gerdes J., Schwab U., Lemke H. and Stein H. (1983). Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31, 13-20.
12. Johnson L.A., Lavin P., Moertel C.G., Weiland L., Dayal Y., Doos W.G., Geller S.A., Cooper H.S., Nime F., Masse S., Simson I.W., Summer H., Folsch E. and Engstrom P. (1983). Carcinoids: The association of histologic growth pattern and survival. Cancer 51, 882-889.
13. Kawahara M., Kammori M., Kanauchi H., Noguchi C., Kuramoto S., Kaminishi M., Endo H. and Takubo K. (2002). Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours. Eur. J. Surg. Oncol. 28, 140-146.
14. Key G., Becker M.H., Baron B., Duchrow M., Schluter C., Askaa J. and Gerdes J. (1993). New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab. Invest. 68, 629-636.
15. Klöppel G., Solcia E., Capella C. and Heitc Ph. (1999). Classification of neuroendocrine tumours. Ital. J. Gastroenterol. Hepatol. Suppl. 2, 111-116.
16. La Rosa S., Sessa F., Cva C., Leone B.E., Klersy C., Rindi G. and Solcia E. (1996). Prognostic criteria in non-functioning pancreatic endocrine tumours. Virchows Arch. 429, 323-333.
17. Laitinen K.L., Soini Y., Mattila J. and Paakko P. (2000). Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity. Cancer 88, 1590-1598.
18. Li C.C., Xu B., Hirokawa M., Qian Z., Yoshimoto K., Horiguchi H., Tashiro T. and Sano T. (2002). Alterations of E-cadherin, α-catenin and β-catenin expression in neuroendocrine tumors of the gastrointestinal tract. Virchows Arch. 440, 145-154.
19. Moyana T.N., Xiang J., Senthilselvan A. and Kulaga A. (2000). The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: Importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity. Arch. Pathol. Lab. Med. 124, 570-576.
20. Oberdorfer S. (1907). Karzinoide Tumouren des Dünndarms. Frankfurt Zeitschr. Pathol. 1, 426-432.
21. Pelosi G., Bresaola E., Bogina G., Pasini F., Rodella S., Castelli P., Iacono C., Serio G. and Zamboni G. (1996). Endocrine tumours of the pancreas: Ki-67 immuno-reactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum. Pathol. 27, 1124-1134.
22. Portela-Gomes G.M., Stridsberg M., Johansson H. and Grimelius L. (1999). Co-localization of synaptophysin with different neuroendocrine hormones in the human gastrointestinal tract. Histochem. Cell Biol. 111, 49-54.
23. Rindi G., Azzoni C., La Rosa S., Klresy C., Paolotti D., Rappel S., Stolte M., Capella C., Bordi C. and Solcia E. (1999). ECL cell tumour and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis. Gastroenterology 116, 532-542.
24. Shimizu T., Tanaka S., Haruma K., Kitadai Y., Yoshihara M., Sumii K., Kajiyama G. and Shimamoto F. (2000). Growth characteristics of rectal carcinoid tumors. Oncol. 5, 229-237.
25. Thomas R.M., Baybick J.H., Elsayed A.M. and Sobin L.H. (1994). Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer 73, 2053-2058.